Takeda joins other pharma majors in open innovation genomics consortium
This article was originally published in Scrip
Executive Summary
Takeda has become the latest pharma firm to join the international Structural Genomics Consortium (SGC), adding more industry weight to the open access research initiative that makes all of its findings available to researchers worldwide without patent or other restrictions.